On the contrary, plasma levels of C3, a key mediator of the complement cascade exerting direct effector functions in inflammation and innate immune activation [27], were abnormally increased in AChR-MG, but not in MuSK-MG patients compared to controls (Figure 1). This evidence concerns the gene C3 and myasthenia gravis.